![Scott T. Megaffin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Scott T. Megaffin
Directeur Général chez Adiso Therapeutics, Inc.
Postes actifs de Scott T. Megaffin
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioNJ, Inc.
![]() BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Directeur/Membre du Conseil | - | - |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Directeur Général | 01/01/2022 | - |
Historique de carrière de Scott T. Megaffin
Anciens postes connus de Scott T. Megaffin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01/06/2006 | - |
Adastra Pharmaceuticals, Inc.
![]() Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Directeur/Membre du Conseil | 03/01/2019 | - |
Directeur Général | 03/01/2019 | - | |
Adolor Corp.
![]() Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Sales & Marketing | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Yamanouchi Pharma America, Inc. | Sales & Marketing | - | - |
TRAWS PHARMA, INC. | Corporate Officer/Principal | 29/04/2011 | - |
Formation de Scott T. Megaffin
Pittsburg State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
TRAWS PHARMA, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Adolor Corp.
![]() Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Adastra Pharmaceuticals, Inc.
![]() Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
BioNJ, Inc.
![]() BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Yamanouchi Pharma America, Inc. | |
Adiso Therapeutics, Inc.
![]() Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Health Technology |
- Bourse
- Insiders
- Scott T. Megaffin
- Expérience